XML 51 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Impairment, long-lived asset $ 0 $ 0  
Finance lease, liability 0 0  
Exchange ratio     1
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Cost share R&D expenses, gross 727,000 233,000  
Threshold per asset 5,000    
Cost Share Project, Property and Equipment Purchases      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Cost share R&D expenses, gross $ 36,000 $ 65,000  
Employee Stock Option      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from earnings per share (in shares) 9,470,382 11,426,653  
Restricted Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from earnings per share (in shares) 1,252,166